Risk factors
Personalis (PSNL) risk factors
Item 1A of every Personalis, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors71 risks7 new5 dropped12 reworded
Financial losses remained steady at $81.3 million with an accumulated deficit reaching $631.3 million. New tariff and international trade risks were added alongside expanded disclosures on tax legislation impacts. Customer dependency risks continue to feature key partners like Moderna and Natera.
Filed Feb 26, 2026 - FY2024 10-K risk factors69 risks
Personalis faces continuous operating losses, reliance on sole suppliers like Illumina, and strict regulatory hurdles in clinical genomic testing.
Filed Feb 27, 2025